Addiction Toxicology Case Conference - December 2022

Fentanyl Infiltration into the Black Tar Heroin Market - Implications for Buprenorphine Use

Case 1: A pregnant patient with worsening symptoms of opioid withdrawal despite a standard buprenorphine induction.

Case 2: Fentanyl adulteration of pills and planning a buprenorphine induction for a patient who is not yet in withdrawal.

Series Moderators

• Timothy J. Wiegand, MD, FACMT, DFASAM (ACMT/ASAM Expert), Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY  
• Gloria J. Baciewicz, MD (ASAM Expert), Addiction Psycharcist, Strong Recovery; Professor of Clinical Psychiatry, Department of Psychiatry, University of Rochester Medical Center, Rochester, NY

Panelists

• Kurt C. Kleinschmidt, MD, FACMT, FASAM (ACMT/ASAM Expert), Professor of Emergency Medicine, Medical Toxicology, UT Southwestern Medical Center; Medical Director, Perinatal Intervention Program, Parkland Health and Hospital System, Dallas, TX
• Nancy Onisko, DO, FACEP (Guest Expert), Assistant Professor, Department of Emergency Medicine, UT Southwestern; Assistant Director, Perinatal Intervention Program, Parkland Hospital and Health System, Dallas, TX
• Jeanmarie Perrone, MD, FACMT (ACMT Expert), Professor, Department of Emergency Medicine; Director, Division of Medical Toxicology and Addiction Medicine Initiatives, Perelman School of Medicine; Director, Penn Center for Addiction Medicine and Policy, University of Pennsylvania, Philadelphia, PA

About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.

This webinar is open to the public.